Original Source(s)
Related Content
FDA approves oral dermatomyositis therapy
Phase 3 findings show improvements in physical function and skin disease activity.
August 28, 2026
-
2 min
Biomarker may flag early pregnancy risk
A protein was linked experimentally to trophoblast invasion.
September 4, 2026
-
4 min
Extended antiviral therapy may not improve long COVID
Nirmatrelvir–ritonavir for up to 25 days failed to improve cognitive, autonomic, or exercise symptoms compared with placebo in a phase 2 trial.
September 4, 2026
-
4 min